S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Teladoc Health (TDOC) Stock Forecast, Price & News

-0.17 (-0.52%)
(As of 05/20/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
5.05 million shs
Average Volume
15.40 million shs
Market Capitalization
$5.28 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

Teladoc Health logo

About Teladoc Health

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.


It's Time to Book an Appointment for Teladoc Stock
Teladoc has some issues to sort through but this could ultimately amount to a tremendous buy opportunity for a stock with a healthy long-term outlook.
Down 77%, This Stock Is a Buy Right Now
Teladoc Shareholder Alert
Amazon Should Buy Teladoc Right Now -- Seriously
Teladoc Health Whale Trades Spotted
See More Headlines

Industry, Sector and Symbol

Offices & clinics of medical doctors
Year Founded

Sales & Book Value

Annual Sales
$2.03 billion
Cash Flow
$0.44 per share
Book Value
$56.72 per share


Net Income
$-428.79 million
Net Margins
Pretax Margin




Free Float
Market Cap
$5.28 billion

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.49 out of 5 stars

Medical Sector

142nd out of 1,416 stocks

Offices & Clinics Of Medical Doctors Industry

2nd out of 13 stocks

Analyst Opinion: 4.1Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -

Teladoc Health (NYSE:TDOC) Frequently Asked Questions

Is Teladoc Health a buy right now?

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 19 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Teladoc Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
View analyst ratings for Teladoc Health
or view top-rated stocks.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Teladoc Health

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) posted its quarterly earnings results on Wednesday, April, 27th. The health services provider reported ($41.58) earnings per share for the quarter, missing analysts' consensus estimates of ($0.58) by $41.00. Teladoc Health had a negative trailing twelve-month return on equity of 2.12% and a negative net margin of 321.94%. During the same quarter in the prior year, the business earned $0.13 earnings per share.
View Teladoc Health's earnings history

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its FY 2022 earnings guidance on Tuesday, March, 15th. The company provided earnings per share guidance of $-1.600-$-1.400 for the period, compared to the consensus EPS estimate of $-1.780. The company issued revenue guidance of $2.55 billion-$2.65 billion, compared to the consensus revenue estimate of $2.57 billion.

What price target have analysts set for TDOC?

27 equities research analysts have issued 12 month price targets for Teladoc Health's stock. Their forecasts range from $30.00 to $210.00. On average, they expect Teladoc Health's stock price to reach $88.11 in the next year. This suggests a possible upside of 169.1% from the stock's current price.
View analysts' price targets for Teladoc Health
or view top-rated stocks among Wall Street analysts.

Who are Teladoc Health's key executives?
Teladoc Health's management team includes the following people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 50, Pay $1.64M)
  • Ms. Mala Murthy, Chief Financial Officer (Age 58, Pay $880.77k) (LinkedIn Profile)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 47, Pay $650.77k)
  • Mr. Andrew Turitz, Sr. VP of Corp. Devel. (Age 49, Pay $573.6k) (LinkedIn Profile)
  • Mr. Claus Torp Jensen Ph.D., Chief Innovation Officer
  • Dr. George Byron Brooks, Co-Founder
  • Mr. Richard J. Napolitano, Sr. VP, Chief Accounting Officer & Controller (Age 55)
  • Mr. Patrick Thomas Feeley C.F.A., CPA, VP of Investor Relations
  • Ms. Courtney Kraemer McLeod, Director of Communication
  • Ms. Stephany Verstraete, Chief Marketing Officer & Engagement Officer (Age 52) (LinkedIn Profile)
What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among Teladoc Health's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), DocuSign (DOCU), Salesforce (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (12.14%), Vanguard Group Inc. (8.21%), Baillie Gifford & Co. (6.66%), Sumitomo Mitsui Trust Holdings Inc. (5.49%), Nikko Asset Management Americas Inc. (5.24%) and Kinnevik AB publ (2.29%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David Travers, David William Sides, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Sandra L Fenwick, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends for Teladoc Health

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Verition Fund Management LLC, Kinnevik AB publ , Zurcher Kantonalbank Zurich Cantonalbank , Renaissance Technologies LLC, IMC Chicago LLC, Sumitomo Mitsui Financial Group Inc., UBS Group AG, and Discovery Value Fund. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David Travers, David William Sides, Jason N Gorevic, Karen L Daniel, Mala Murthy, Sandra L Fenwick, and Stephany Verstraete.
View insider buying and selling activity for Teladoc Health
or view top insider-selling stocks.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, SG Americas Securities LLC, ARK Investment Management LLC, Greenhaven Road Investment Management L.P., Worldquant Millennium Advisors LLC, Federated Hermes Inc., Burleson & Company LLC, and Banco Santander S.A..
View insider buying and selling activity for Teladoc Health
or or view top insider-buying stocks.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $32.74.

How much money does Teladoc Health make?

Teladoc Health has a market capitalization of $5.28 billion and generates $2.03 billion in revenue each year. The health services provider earns $-428.79 million in net income (profit) each year or ($43.040010) on an earnings per share basis.

How many employees does Teladoc Health have?

Teladoc Health employs 5,100 workers across the globe.

Does Teladoc Health have any subsidiaries?

The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..

When was Teladoc Health founded?

Teladoc Health was founded in 2002.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at (203) 635-2002 or via email at [email protected].

This page was last updated on 5/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.